Pershing Square Capital
View Older Stories View More Recent Stories
-
Valeant Pharma (VRX), Pershing Square plan to raise Allergan (AGN) bid by $15 per share - WSJ
-
Pershing Square Capital Raises Stake in Platform Specialty Products (PAH) to 26.1%
-
Form SC 13D Platform Specialty Produ Filed by: Pershing Square Capital Management, L.P.
-
Allergan (AGN) Files to Block Ackman's Pershing Square from Voting at Dec. Meeting (VRX)
-
Top 10 News for 9/29 - 10/3: Ebola Lands in U.S.; eBay Says 'Sayonara' to PayPal; Ford Cuts Outlook
-
Fannie (FNMA), Freddie (FMCC) Stockholders Hold Out Hope as Investors Press On With Government Suits
-
Market Wrap: Private Employment Expands in Sept.; BofA CEO Becomes Chairman; U.S. Secret Service Director Resigns
-
Ackman's Pershing Square Holdings Sees Robust Demand for Amsterdam Listing
-
Freddie Mac (FMCC), Fannie Mae (FNMA) investors suit against U.S. thrown out - Bloomberg
-
SEC Charges Two with Insider Trading on Pershing Square's Announcement on Herbalife
-
Allergan (AGN) Responds to Recent Valeant (VRX) Publication
-
Form SC 13D/A ALLERGAN INC Filed by: Pershing Square Capital Management, L.P.
-
Pershing Square IPO said to have demand for all shares and greenshoe - Bloomberg
-
Pershing Square Receives FTC early termination notice related to a deal with Air Products (APD)
-
Allergan (AGN), Valeant (VRX), Pershing Square Enter Litigation Settlement; Special Meeting Date Set
-
Pershing Square Submits Additional Requests for Allergan (AGN) Special Meeting
-
Pershing Square Submits Additinal Special Meeting Requests to 1.29% of Allergan (AGN) Shareholders
-
Allergan (AGN) Comments on Pershing's Delivery of Additional Shareholder Requests; Reaffirms Value Stance (VRX)
-
Bill Ackman Sends Letter to Allergan's (AGN) Board
-
Form SC 13D/A ALLERGAN INC Filed by: Pershing Square Capital Management, L.P.
-
Allergan (AGN) Updates on Validity of Pershing Square's Delivery of Written Requests
-
Bill Ackman's Pershing Square Holdings fund up 31.2% YTD - Reuters
-
UPDATE: Valeant Pharma (VRX), Pershing Square Win Bid to Fast-Track Allergan (AGN) Suit
-
Allergan (AGN) Requests Expedited Schedule for Prelim. Injunction Against Valeant (VRX), Pershing Square
-
Allergan (AGN) Special Meeting Set for Dec. 18 - Bloomberg
-
Burger King (BKW) Gains Bolster Solid FY14 Performance for Pershing Square's Ackman
-
Allergan (AGN) Affirms Receipt of Special Meeting Request from Pershing Square (VRX)
-
Ackman's Pershing Square Approved to Call Special Meeting of Allergan (AGN) Shareholders (VRX)
-
Allergan (AGN) Approached Salix Pharma (SLXP) - DJ
-
Ackman's Pershing Square Sues U.S. Over 2008 Fannie, Freddie Bailout (FNMA) (FMCC)
-
Ackman's Pershing Square Files Suit Against U.S. Over Freddie Mac (FMCC), Fannie Mae (FNMA)
-
Ackman's Pershing Square 13F Shows Lower Stake in Canadian Pacific (CF), Exits Home Properties (HME)
-
Form 13F-HR Pershing Square Capital For: Jun 30
-
Pershing Square Says 'Toehold' in Allergan (AGN) Wasn't Illegal
-
UPDATE: Valeant Pharma (VRX): SEC Investigating Valeant /Pershing Bid for Allergan (AGN) - DJ
-
Herbalife (HLF) May Be Unable to Refi 2016 Credit Line - Bloomberg Citing Ackman
-
Form SC 13D/A ALLERGAN INC Filed by: Pershing Square Capital Management, L.P.
-
Allergan (AGN) Responds to ISS and Glass Lewis Recommendations, Says Offer Still Grossly Inadequate,
-
Glass Lewis Backs Pershing Square's Call for Allergan (AGN) Special Meeting
-
Top 10 News for 7/28 - 8/1: FOMC Tapers Further, Rates Still Intact; Jobs Growth Elusive in July; Argentina Defaults. Again.
-
Valeant Pharmaceuticals (VRX), Pershing Call Allergan (AGN) Lawsuit Frivolous
-
Allergan (AGN) Files Complaint Against Valeant (VRX), Pershing Square; Alleges Violation of Securities Laws
-
Herbalife (HLF) Ticks Higher, Shorts Expand Positions into Q2 Report
-
Market Wrap: CPI Gains 0.3% in June; Another Ack-Attack on Herbalife; Apple Bruised on Q2 Phone Sales
-
Herbalife's (HLF) Squeeze Higher Continues Following Pershing Square Presentation
-
Herbalife (HLF) Comments on Pershing Square's Three-Hour Presentation; Says Ackman Over-Promised, Under-Delivered on Short Bet
-
Herbalife (HLF) Can Hit $300/sh in Next 5-10 Years, Says Chapman - CNBC
-
Herbalife (HLF) Goes Red-to-Green Early in Ackman Presentation
-
Herbalife (HLF) Down 1% as Pershing Square Presentation Set to Start
-
Herbalife (HLF) on Watch Ahead of Pershing Square Presentation

